Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis
Employers For employers, GLP-1 coverage decisions can impact healthcare costs, employee satisfaction, and retention
At Healthy Nest Nutrition, we teach you how to eat for your goals, so that youll be able to keep your loss and maintain a healthy lifestyle
Studies indicate improved mobility and faster recovery from joint inflammation or injury, making it suitable for regenerative orthopedic research applications
What it would do is close the bulks-list pathway for routine future use of these three drugs removing one of the last broad legal foundations for large-volume compounding outside of patient-specific or shortage scenarios
Besides Sun Pharma, a growing roster of Indian drugmakers is gearing up to enter the GLP1 space, lining up generic versions of semaglutide ahead of the patent expiry in March 2026 and tap into the demand: Dr Reddys Laboratories Hyderabadbased Dr Reddys Laboratories has also secured regulatory approval for a generic semaglutide product, receiving DCGI clearance earlier this week to manufacture and sell a generic version of Ozempic for the treatment of type 2 diabetes
